
Walt Disney Just Delivered a Knockout Punch to This Already Struggling Industry
The launch of this service also likely marks the beginning of the end of the cable television industry as known today, even if it doesn't mean an immediate and complete collapse.
Here's what investors need to know.
Disney is taking on already-battered competition
The world knew it was coming sooner or later -- CEO Bob Iger confirmed it in early 2024. The only question then was the timing, price, and the prospective impact that a cooperative sports-centric streaming package from Disney, Fox, and Warner Bros. Discovery might have on the overall marketability of a streaming service that only included ESPN's programming. That joint venture between Disney, Warner, and Fox has since been indefinitely blocked by a federal court, but Disney is clearly proceeding with its plans to offer an affordable version of ESPN that doesn't require a cable subscription.
That's a problem for cable companies like Comcast 's (NASDAQ: CMCSA) Xfinity and Charter Communications ' (NASDAQ: CHTR) Spectrum, both of which were already bleeding cable customers.
The graphic below tells the tale. Xfinity shed another 427,000 cable-television customers last quarter to bring the count down to just under 12.1 million, for perspective, extending a long-lived decline from the 2013 peak of nearly 23 million. Spectrum's TV headcount now stands at 12.7 million customers, thanks to last quarter's loss of 127,000, well down from its peak more than a decade ago.
These two cable powerhouses aren't unique in their customer attrition either, even if they are the biggest with the most customers to lose. Consumer market research outfit eMarketer reports the total number of paying cable-television customers in the United States has been culled by one-third of its 2013 peak, with non-cable households eclipsing cable TV's headcount of last year.
The advent of a streaming version of ESPN, however, could prove even more problematic for the cable business by accelerating this attrition for a couple of related reasons.
Ripe for (major) disruption
Again, the cable-television industry was already on the ropes, and as such, makes an easy target for a novel newcomer.
To the extent the cable TV business had any hope for a turnaround, though, it's now been wiped away.
See, Disney's ESPN isn't just a well-known and well-loved sports venue. It's the leading name of the sports-television market, accounting for nearly 30% of the nation's total sports viewership, according to numbers from TV ratings agency Nielsen. Adding Disney's ABC sports-branded programming to the mix pumps that number up to more than 40%.
Connect the dots. It's not just the biggest name in the business. Disney's got size-based leverage to exert in a myriad of ways.
Don't be surprised to see other studios mirror Disney's move, either, albeit with less scale and lower-priced streaming bundles of their sports-based programming.
Fox and Warner Bros. Discovery have already shown interest in looking beyond conventional cable for distribution of their sports-centric content, while several standard streaming services like Paramount 's Paramount+, Warner's Max, and even Amazon 's Prime also air the occasional exclusive sporting event. Most professional sports leagues and even a handful of individual teams now even offer their own streaming packages.
The point is, once Disney blazes the trail, the launch of many other new sports-centric streaming platforms from major studios wouldn't be a major leap.
That's a problem for the cable television industry for one simple reason. That is, live sports is the single biggest reason consumers still pay for cable television. A recent survey performed by CableTV.com indicates that 27% of these subscribers still pay a steep monthly price specifically for access to sports programming. The next-nearest reason is consumers' comfort with conventional cable, although it's difficult to imagine most of these people not being comfortable enough at this point to at least consider an alternative.
Whatever's in the cards, it works against cable companies' bottom lines.
Finally, at a turning point -- or the edge of a cliff
There was a time when content producers and content creators like Disney were in a symbiotic relationship, where the two parties helped one another without hurting one another. That's not the situation anymore. These relationships evolved into competition just a few years back. Now, with Disney's direct foray into the most important sliver of the television arena, it's become a full-blown competition that cable companies can't win -- studios just don't need middleman distributors anymore.
More to the point for investors, what's bad for an already beleaguered cable TV industry is good for Disney, and perhaps even disproportionately better.
Whereas the cable industry only pays Disney on the order of $10 per month per subscriber for the right to air ESPN's programming, Disney will be collecting three times that amount by selling the exact same content directly to subscribers. While sports currently makes up a little less than one-fifth of Walt Disney's revenue and roughly one-tenth of its operating income, both could swell if this new streaming-ESPN venture works out.
Bottom line? Cable stocks like Charter and Comcast were already tough to own. Now they're even less compelling. Conversely, The Walt Disney Company is finally addressing the ongoing shrinkage of its linear (cable) TV arm with a business model it's already proven it's great at. It brings plenty of marketing firepower to the table as well. This just might be the catalyst needed for the long-awaited turnaround from Disney stock.
Should you invest $1,000 in Walt Disney right now?
Before you buy stock in Walt Disney, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Walt Disney wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $635,275!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $826,385!*
Now, it's worth noting Stock Advisor 's total average return is967% — a market-crushing outperformance compared to171%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of May 12, 2025
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. James Brumley has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Walt Disney, and Warner Bros. Discovery. The Motley Fool recommends Comcast. The Motley Fool has a disclosure policy.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
2 minutes ago
- Globe and Mail
J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?
Johnson & Johnson JNJ announced strong second-quarter results earlier this month. The drug and medical device giant beat estimates for both earnings and sales. Despite the loss of exclusivity ('LOE') of its blockbuster drug, Stelara, its Innovative Medicine unit once again outperformed expectations, with sales of all key drugs Darzalex, Erleada and Tremfya beating estimates. The new drugs also contributed significantly to sales. Importantly, its MedTech sales improved from first-quarter levels, driven by strong momentum in Cardiovascular, Surgery and Vision segments despite continued headwinds in China. But what caught investor attention is the fact that J&J raised its sales expectations for 2025 by around $2.0 billion at the mid-point to reflect a strong operational performance in the first half, coupled with currency tailwinds. The sales guidance was raised from a range of $91.0 billion-$91.8 billion to $93.2 billion-$93.4 billion. The sales range indicates growth in the range of 5.1%-5.6% versus the prior expectation of 2.6%-3.6%. The adjusted earnings per share guidance was raised from a range of $10.50-$10.70 to $10.80-$10.90, driven by top-line strength, the favorable impact of foreign currency and lowered tariff impact. J&J halved its expectations for tariff-related costs this year from $400 million to $200 million. J&J expects operational sales growth in both the Innovative Medicine and MedTech segments to be higher in the second half than in the first. Newly launched products should drive better growth in the Innovative Medicine segment in the second half despite the impact of Stelara LOE and Medicare Part D redesign. The growth is expected to be driven by its key products, such as Darzalex, Tremfya, Spravato and Erleada as well as new drugs like Carvykti, Tecvayli and Talvey and new indications, including Tremfya in inflammatory bowel disease indications and Rybrevant in non-small cell lung cancer. In the MedTech segment, the increased adoption of newly launched products in Cardiovascular, Surgery and Vision is likely to drive growth. However, China will continue to be a headwind in 2025. Sales are expected to be higher in the second half than the first half as the business moves past tougher first-half comps and new products gain momentum throughout 2025. We believe that J&J should be able to maintain the strong momentum of the first half in the second half. In fact, J&J expects growth to accelerate from 2026. ABBV & BMY Also Raise Guidance Other drugmakers that also raised their financial outlook for the year, along with their second-quarter results, are AbbVie ABBV and Bristol-Myers BMY. ABBV raised its full-year 2025 EPS guidance to $11.88-$12.08, up from its prior $11.67-$11.87 range.' Bristol-Myers raised its annual revenue guidance to $46.5-$47.5 billion from $45.8-$46.8 billion. BMY, however, cut its EPS outlook due to IPRD charges related to its recent deal with BioNTech BNTX for the global co-development and co-commercialization of BNTX's investigational bispecific antibody BNT327 across numerous solid tumor types. JNJ's Price Performance, Valuation and Estimates J&J's shares have outperformed the industry year to date. The stock has risen 17.6% in the year-to-date period against a 3.3% decrease of the industry. Image Source: Zacks Investment Research From a valuation standpoint, J&J is slightly expensive. Going by the price/earnings ratio, the company's shares currently trade at 15.0 forward earnings, slightly higher than 14.29 for the industry. The stock is, however, trading below its five-year mean of 15.68. Image Source: Zacks Investment Research The Zacks Consensus Estimate for 2025 earnings has risen from $10.62 per share to $10.86 over the past 30 days, while that for 2026 has risen from $11.0 to $11.36 over the same timeframe. Image Source: Zacks Investment Research J&J has a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks Names #1 Semiconductor Stock This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Bristol Myers Squibb Company (BMY): Free Stock Analysis Report Johnson & Johnson (JNJ): Free Stock Analysis Report AbbVie Inc. (ABBV): Free Stock Analysis Report BioNTech SE Sponsored ADR (BNTX): Free Stock Analysis Report


Globe and Mail
2 minutes ago
- Globe and Mail
Stock Market News for Aug 4, 2025
U.S. stocks tumbled on Friday, with the S&P 500 recording its biggest daily percentage decline in over two months, as hefty tariffs slapped on dozens of countries by President Donald Trump and an unexpectedly weak jobs report raised concerns over a weakening economy. All three major indexes ended in negative territory. How Did The Benchmarks Perform? The Dow Jones Industrial Average (DJI) slid 1,2% or 542.40 points, to finish at 43,588.58 points. The S&P 500 declined 1.6%, or 101.38 points, to end at 6,238.01 points, posting its worst day since May 21. Consumer discretionary, tech and financial stocks were the worst performers. The Consumer Discretionary Select Sector SPDR (XLY) declined 2.4%. The Financials Select Sector SPDR (XLF) and the Technology Select Sector SPDR (XLK) slid 2.2 and 1.9%, respectively. Eight of the 11 sectors of the benchmark index ended in negative territory. The tech-heavy Nasdaq fell 2.2%, or 472.32 points, to close at 20,650.13 points, recording its biggest single-day decline since April 21. The fear gauge CBOE Volatility Index (VIX) was up 21.89% to 20.38. Decliners outnumbered advancers on the NYSE by a 2.17-to-1 ratio. On the Nasdaq, a 2.69-to-1 ratio favored declining issues. A total of 19.51 billion shares were traded on Friday, higher than the last 20-session average of 18.44 billion. Trump's New Tariffs, Weak Jobs Data Dent Investors' Confidence Trump signed an executive order hours before the Aug. 1 tariff deadline and slapped hefty duties on several trading partners of the United States, including Brazil, Canada, India and Taiwan, as these countries scrambled to work out fairer trade deals. Investors grew concerned once again as they believe that hefty tariffs could weigh on an already weakening economy and push inflation further up. Investors' confidence took a further hit after fresh data showed that jobs growth unexpectedly slowed in July, while June's numbers were downwardly revised, suggesting that the labor market is likely shrinking. Bank stocks took a hit on concerns that a slowing economy could impact loan growth. Shares of JPMorgan Chase & Co. ( JPM ) fell 2.3%, while Bank of America Corporation ( BAC ) and Wells Fargo & Company ( WFC ) declined 3.4% and 3.5%, respectively. This, however, raised hopes that the Federal Reserve will cut interest rates in its September policy meeting. The weak jobs data raised market expectations of a 25-basis-point rate cut in September to 86.5%, according to the CME's FedWatch Tool, up from 37.7% in Thursday's session. Amazon Weighs on Broader Market E-commerce giant Inc. ( AMZN ) was the biggest drag on all three major indexes. Amazon topped both earnings and revenue estimates. The company reported second-quarter earnings of $1.68 per share, beating the Zacks Consensus Estimate of $1.33 per share. The e-commerce giant posted revenues of $167.7 billion for the quarter, surpassing the Zacks Consensus Estimate by 3.32% However, the company's shares declined 8.3% after it failed to meet the expectations for its Amazon Web Services. Amazon Web Services revenues grew 18% in the second quarter, but its growth rate lagged Microsoft Corporation's ( MSFT ) Azure's 39% and Alphabet, Inc.'s ( GOOGL ) Google Cloud's 32% growth rate. Amazon has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Economic Data The Labor Department reported on Friday that nonfarm payrolls increased by just 73,000 in July, sharply lower than analysts' expectations of a rise of 100,000. June's jobs growth was downwardly revised to just 14,000, from 147,000, while May's numbers totaled just 19,000 after being cut down from the initially reported 125,000. The unemployment rate jumped to 4.2% in July as household employment declined. Weekly Roundup All three indexes ended lower for the week. The Dow lost 2.9% for the week. The S&P 500 was down 2.4% for the week, while the Nasdaq lost 2.2%. Zacks Names #1 Semiconductor Stock This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN): Free Stock Analysis Report Bank of America Corporation (BAC): Free Stock Analysis Report Wells Fargo & Company (WFC): Free Stock Analysis Report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Alphabet Inc. (GOOGL): Free Stock Analysis Report


Globe and Mail
6 minutes ago
- Globe and Mail
HNI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of HNI Corporation Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of HNI Corporation (NYSE: HNI) and Steelcase Inc. is fair to HNI shareholders. Upon closing of the proposed transaction, HNI shareholders will own approximately 64% of the combined company. Halper Sadeh encourages HNI shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@ or zhalper@ The investigation concerns whether HNI and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for HNI shareholders; and (2) disclose all material information necessary for HNI shareholders to adequately assess and value the merger consideration. On behalf of HNI shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome.